Best deals to access real time data! |
|
Big Cap Pro
Monthly Subscription
for only
|
|
Small Cap Pro
Monthly Subscription
for only
|
|
DDE w/Realtime (Monthly)
Monthly Subscription
for only
|
|
VAT not included
|
|
After Hours Last Trade |
Last $ 1.18 ▲ 0.05 (4.42%) | |
| Company Name | Stock Ticker Symbol | Market | Type |
|---|---|---|---|
| Cleveland BioLabs Inc | CBLI | NASDAQ | Common Stock |
| Price Change | Change Percent | Stock Price | High Price | Low Price | Open Price | Close Price | Last Traded  |
|
|---|---|---|---|---|---|---|---|---|
| 0.06 | 5.61% | 1.13 | 1.28 | 1.00 | 1.28 | 1.07 | 00:00:07 |
| Bid Price | Ask Price | Spread | Spread % | News | |
|---|---|---|---|---|---|
| 0.90 | 1.15 | 0.25 | 21.74% | - | - |
| Stock Trades | Traded Volume | VWAP | Dollar Volume | Average Volume | 52 Week Range |
|---|---|---|---|---|---|
| 1,307 | 435,223 | $ 1.16 | $ 502,772 | 48,559 | 0.50 - 2.17 |
| Last Trade Time | Type | Quantity | Stock Price | Currency |
|---|---|---|---|---|
| 18:09:41 | 29 | $ 1.15 | USD |
Cleveland BioLabs Financials
| Market Cap | Shares in Issue | Profit/Loss | Earnings Per Share (EPS) | PE Ratio | Float |
|---|---|---|---|---|---|
| $ 12.77M | 11.30M | $ -3.61M | -0.33 | - | 7.64M |
| Short Interest | Dividends Per Share | Dividend Yield | Ex-Div Date | Insider B/S | Insider % Owned |
|---|---|---|---|---|---|
| - | $ - | 0.00% | - | 32.40% |
Cleveland BioLabs News
Loading Messages....
|
|
{{bbMessage.M_Alias}} {{bbMessage.MSG_Date}} {{bbMessage.HowLongAgo}} {{bbMessage.MSG_ID}} {{bbMessage.MSG_Subject}} |
Loading Messages....
Historical CBLI Price Data
| Period † | Open | High | Low | VWAP | Avg. Daily Vol | Change | % |
|---|---|---|---|---|---|---|---|
| 1 Week | 1.02 | 1.28 | 0.70101 | 0.9317016 | 91,724 | 0.11 | 10.78% |
| 1 Month | 0.71 | 1.28 | 0.515 | 0.8254077 | 70,580 | 0.42 | 59.15% |
| 3 Months | 0.65 | 1.28 | 0.50 | 0.8469038 | 55,801 | 0.48 | 73.85% |
| 6 Months | 1.45 | 1.60 | 0.50 | 0.8910477 | 32,419 | -0.32 | -22.07% |
| 1 Year | 1.50 | 2.17 | 0.50 | 1.11 | 24,210 | -0.37 | -24.67% |
| 3 Years | 1.53 | 5.55 | 0.50 | 4.05 | 139,045 | -0.40 | -26.14% |
| 5 Years | 0.2603 | 7.24 | 0.19 | 4.04 | 137,070 | 0.8697 | 334.11% |
Cleveland BioLabs Description
| Cleveland BioLabs Inc is a biopharmaceutical company. The company is developing novel approaches to activate the immune system and address serious medical needs. Its proprietary platform of Toll-like immune receptor activators has applications in mitigation of radiation injury and immuno-oncology. Its lead product candidate is entolimod, an immuno-stimulatory agent, which is developed as a radiation countermeasure and an immunotherapy for oncology and other indications. Entolimod is a Toll-like receptor 5 (TLR5) agonist, which is developed as a radiation countermeasure for prevention of death from Acute Radiation Syndrome (ARS), and as an oncology drug. |
